Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

102 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparative effectiveness of beta-interferons and glatiramer acetate for relapsing-remitting multiple sclerosis: systematic review and network meta-analysis of trials including recommended dosages.
Melendez-Torres GJ, Armoiry X, Court R, Patterson J, Kan A, Auguste P, Madan J, Counsell C, Ciccarelli O, Clarke A. Melendez-Torres GJ, et al. Among authors: auguste p. BMC Neurol. 2018 Oct 3;18(1):162. doi: 10.1186/s12883-018-1162-9. BMC Neurol. 2018. PMID: 30285675 Free PMC article. Review.
Accurate diagnosis of latent tuberculosis in children, people who are immunocompromised or at risk from immunosuppression and recent arrivals from countries with a high incidence of tuberculosis: systematic review and economic evaluation.
Auguste P, Tsertsvadze A, Pink J, Court R, Seedat F, Gurung T, Freeman K, Taylor-Phillips S, Walker C, Madan J, Kandala NB, Clarke A, Sutcliffe P. Auguste P, et al. Health Technol Assess. 2016 May;20(38):1-678. doi: 10.3310/hta20380. Health Technol Assess. 2016. PMID: 27220068 Free PMC article. Review.
Clinical effectiveness and cost-effectiveness of use of therapeutic monitoring of tumour necrosis factor alpha (TNF-α) inhibitors [LISA-TRACKER® enzyme-linked immunosorbent assay (ELISA) kits, TNF-α-Blocker ELISA kits and Promonitor® ELISA kits] versus standard care in patients with Crohn's disease: systematic reviews and economic modelling.
Freeman K, Connock M, Auguste P, Taylor-Phillips S, Mistry H, Shyangdan D, Court R, Arasaradnam R, Sutcliffe P, Clarke A. Freeman K, et al. Among authors: auguste p. Health Technol Assess. 2016 Nov;20(83):1-288. doi: 10.3310/hta20830. Health Technol Assess. 2016. PMID: 27845027 Free PMC article. Review.
Test accuracy of drug and antibody assays for predicting response to antitumour necrosis factor treatment in Crohn's disease: a systematic review and meta-analysis.
Freeman K, Taylor-Phillips S, Connock M, Court R, Tsertsvadze A, Shyangdan D, Auguste P, Mistry H, Arasaradnam R, Sutcliffe P, Clarke A. Freeman K, et al. Among authors: auguste p. BMJ Open. 2017 Jul 2;7(6):e014581. doi: 10.1136/bmjopen-2016-014581. BMJ Open. 2017. PMID: 28674134 Free PMC article. Review.
Clinical effectiveness and cost-effectiveness of beta-interferon and glatiramer acetate for treating multiple sclerosis: systematic review and economic evaluation.
Melendez-Torres GJ, Auguste P, Armoiry X, Maheswaran H, Court R, Madan J, Kan A, Lin S, Counsell C, Patterson J, Rodrigues J, Ciccarelli O, Fraser H, Clarke A. Melendez-Torres GJ, et al. Among authors: auguste p. Health Technol Assess. 2017 Sep;21(52):1-352. doi: 10.3310/hta21520. Health Technol Assess. 2017. PMID: 28914229 Free PMC article. Review.
Short- and long-term clinical outcomes of use of beta-interferon or glatiramer acetate for people with clinically isolated syndrome: a systematic review of randomised controlled trials and network meta-analysis.
Armoiry X, Kan A, Melendez-Torres GJ, Court R, Sutcliffe P, Auguste P, Madan J, Counsell C, Clarke A. Armoiry X, et al. Among authors: auguste p. J Neurol. 2018 May;265(5):999-1009. doi: 10.1007/s00415-018-8752-8. Epub 2018 Jan 22. J Neurol. 2018. PMID: 29356977 Free PMC article. Review.
102 results